Blending regenerative medicine and a focus on long-term health, Ryan Kent is helping athletes and patients recover faster, avoid invasive procedures, and improve their longevity.

A Phase I/II Clinical Study to assess safety, potency and durability of SR-02 implanted to the abdominal omentum of patients with difficult-to-control T1D

$400,000 award will support characterization and efficacy testing of preclinical SR-03 cell line as a part of IND development. Seraxis is taking meetings at the American Diabetes Association Annual Meeting in Orlando, June 21-24.

Focus on Regenerative Medicine Combined with Best-in-Class Aesthetics Device Offering

GMP-compliant manufacturing puts SR-02 on track to be industry’s second clinical-stage stem cell derived pancreatic islet transplant program.

The third-party auditor’s FDA six-system approach yielded no critical nor major observations of Seraxis’ quality system for the production of GMP-grade organs from pancreas-derived stem cells.

Dr. William Rust, CEO, will present further data on the development of SR-02 and follow-on immune-cloaked SR-03 on Monday, January 8 at 10:30 a.m. PST at Biotech Showcase in San Francisco.

Manuscript describes the unique character of a pancreatic endocrine cell population derived from a non-pluripotent stem cell that closely resembles native islets in composition and in vivo function.

Dr. William Rust, CEO of Seraxis, will deliver a lecture at the IPITA-IXA-CTRMS Joint Congress on October 29 at 10:00 a.m. in San Diego entitled “Novel stem cell-derived islet-like clusters potently control rodent blood glycemia”.

Seraxis will be taking meetings at BIO-Europe, November 6-8, in Munich.

Dr. William Rust will give an oral presentation on Seraxis’ proprietary technology for the production of therapeutic pancreatic organoids from pancreas-derived stem cells, as well as review initial diabetes model data of functional cure of Type 1 Diabetes. Seraxis’ presentation, entitled “Stem-cell Derived Islets for Treating Diabetes”, will be delivered in the session entitled "Transplantation of Islet and Stem Cells Today and Tomorrow".

Attending PHATS since 2014, this year, ZetrOZ showcased sam® X1 and 2.0 to educate attendees on the benefits of sustained acoustic medicine for hockey professionals.

New Precise™ technology provides physicians with more options for custom PRP

SUPMOGO's RecoveryFlex System offers cutting-edge pain relief and performance enhancement through water-activated Advanced Targeting AI. Reduce inflammation, strengthen affected areas, and improve mobility with muscle stimulation and increased blood flow. The customizable app-driven experience provides fast and effective relief on the go.

Clinical investigator and regenerative medicine pioneer Don Buford, MD, is leading the charge to bring the latest advances in mechanobiology and regenerative medicine to 32.5 million knee arthritis sufferers across the United States in a National Institutes of Health-funded study aimed at reducing opioids and surgery.

The Interventional Orthobiologics Foundation Conference is one of the largest gatherings of orthopedic and interventional pain specialists in the United States with a focus on innovation

BIOINCYTE™ is a Next-Generation Autologous Fibrin and Platelet System

The lunch and lecture provided scientific updates on sustained acoustic medicine research in sports medicine, significant product innovations, and the new 2023 Player Performance Package (PPP).

The sam®x1 wireless sustained acoustic medicine device helps sports and regenerative medicine providers return their patients to everyday activities.

The specialized ultrasound treatment is now available to medical professionals across the United States.

Board-certified physicians use the ZetrOZ Systems sustained acoustic medicine device for injury healing and pain relief without invasive surgery or potentially addictive and dangerous medications.

The American Academy of Stem Cell Physicians will be hosting its fall Scientific Congress in Chicago, IL, on Oct. 28, 2022.

Ryan Welter, MD, Ph.D., of Regeneris Medical Boston, pioneers new hair growth technology for men and women using a novel 1,927 nm fractional thulium laser system to deliver platelet-derived growth factors, bypassing the traditional route of scalp injections

Nestled in L.A.'s San Fernando Valley, Regenics' State-of-the-Art Facility and Their Medical Providers Offer Cutting-Edge and Forward-Thinking Healthcare Solutions for Their Patients that Help Them Optimize Every Aspect of Their Physical and Mental Well-being.

New Fibrant Line Changes the Game of Fiber Grafting

The hands-on workshops will be on intra discal injections, bone marrow aspiration and muscular skeleton ultrasound techniques.

American Academy of Stem Cell Physicians will host expert speakers in Stem Cell research on June 17-19, 2022, in Miami.

American Academy of Stem Cell Physicians will meet on June 17-19 and will be offering hands on workshops

Speakers are experts from across the country in stem cell research, lecturing on the recent innovations.

Join the pioneers of Anti-Aging, Regenerative, and Cellular medicine for two incredible days of the latest medical research and how it is applied to clinical practice.

Stemedix and USF have partnered together to facilitate advancements in regenerative medicine offerings to continue to help improve patient outcomes.

Vitamin IV and injection therapy brand continues expansion through Los Angeles, Orange and San Diego Counties

With chiropractic practices suffering due to COVID, Dr. Mike Carrberry, founder of Advanced Medical Integration, speaks on how integrated practices are still flourishing despite the pandemic and economic crisis.

The way for a medical practice to get a handle on the marketing game is to study the approaches of marketers in other business sectors. Advanced Medical Integration released a guide that is the culmination of learning about marketing techniques and applying them to practices that want to transition towards medical integration.

With the ability to extract useful stem cell lines from perinatal materials that are routinely disposed of as medical waste following births, a host of issues are minimized and potential medical development expanded. Wharton's jelly has quickly become recognized as a powerful substance that is easy to access and in which a multitude of uses can be found.

CūtisCare is committed to supporting research and education in wound care and hyperbaric medicine to further its reputation as a quality-first provider of wound care services and to support therapeutic advancements that improve patient care and healing outcomes

This is an IRB-approved clinical trial aimed at reversing aging in humans. It is being conducted as a pay-to-play trial with a $1 million price tag to enroll.